SCYX - SCYNEXIS INC
0.892
-0.007 -0.841%
Share volume: 305,951
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.90
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-06-2024 | 03-12-2025 | 05-15-2025 | 08-13-2025 | 11-05-2025 | 03-04-2026 | |
| Assets | |||||||||
| Total Assets | 118.254 M | 107.806 M | 99.038 M | 90.643 M | 67.915 M | 60.694 M | 51.071 M | 59.027 M | |
| Current Assets | 101.673 M | 94.578 M | 80.463 M | 72.181 M | 52.221 M | 56.498 M | 48.694 M | 40.374 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 21.049 M | 19.742 M | 9.662 M | 10.262 M | 9.725 M | 10.000 M | 10.000 M | 0.000 | |
| Short Term Investments | 21.049 M | 47.044 M | 40.098 M | 43.249 M | 33.665 M | 33.765 M | 23.131 M | 18.772 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 80.244 M | 25.994 M | 28.730 M | 16.051 M | 6.942 M | 11.020 M | 14.797 M | 21.259 M | |
| Total Non-current Assets | 16.581 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 2.475 M | 13.228 M | 18.575 M | 18.462 M | 15.694 M | 4.196 M | 2.377 M | 18.653 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 118.254 M | 107.806 M | 99.038 M | 90.643 M | 67.915 M | 60.694 M | 51.071 M | 59.027 M | |
| Total liabilities | 44.149 M | 47.400 M | 40.509 M | 35.566 M | 17.383 M | 16.227 M | 14.641 M | 9.651 M | |
| Total current liabilities | 27.349 M | 25.233 M | 25.719 M | 24.099 M | 8.957 M | 10.863 M | 8.469 M | 5.734 M | |
| Accounts Payable | 8.918 M | 5.350 M | 4.955 M | 4.569 M | 4.260 M | 6.172 M | 3.467 M | 2.225 M | |
| Other liabilities | 14.313 M | 20.350 M | 13.496 M | 10.173 M | 7.132 M | 4.849 M | 5.365 M | 3.917 M | |
| Current long term debt | 356.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 2.487 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 14.313 M | 20.350 M | 13.496 M | 10.173 M | 7.132 M | 4.849 M | 5.365 M | 3.917 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 74.105 M | 60.406 M | 58.529 M | 55.077 M | 50.532 M | 44.467 M | 36.430 M | 49.376 M | |
| Common stock | 48.246 M | 429.700 M | 430.631 M | 431.612 M | 432.458 M | 433.278 M | 433.832 M | 434.520 M | |
| Retained earnings | -354.836 M | -369.294 M | -372.102 M | -376.535 M | -381.926 M | -388.811 M | -397.402 M | -385.144 M |